Title: The Evolution of the OTC
1The Evolution of the OTC
- A comprehensive approach to technology
commercialization
The Texas AM University System
2Workshop Outcome Goals
- Develop mission oriented criteria for each
institution technology commercialization program - Define spin-off/new company creation models that
work in the Portuguese context - Develop an internal venture opportunity plan for
a university technology from your institution
3Workshop Methodology
- Form teams around universities that have a
technology that may be the basis of a spin-off
company. - If you havent brought a technology, join with
another team - Develop strategic thinking and materials for your
university
4Work Groups
- University groups
- If you did not bring a technology, join with a
university that did - Technology briefing
- What
- Why
- Connection
- Next steps
5The Nine Points A Common Understanding
- Universities should reserve the right to practice
licensed inventions and to allow other non-profit
and governmental organizations to do so - Exclusive licenses should be structured in a
manner that encourages technology development and
use
6The Nine Points
- Strive to minimize the licensing of future
improvements - Universities should anticipate and help to manage
technology transfer related conflicts of interest - Ensure broad access to research tools
7The Nine Points
- Enforcement action should be carefully considered
- Be mindful of export regulations
- Be mindful of the implications of working with
patent aggregators
8The Nine Points
- Consider including provisions that address unmet
needs, such as those of neglected patient
populations or geographic areas, giving
particular attention to improved therapeutics,
diagnostics and agricultural technologies for the
developing world
9A Common Understanding
- The nine points help to guide university
licensing - They are common themes across universities
- They provide the guardrails for licensing
- They help to guide the activities of the
technology transfer office - Is a successful commercialization office all
about the licensing function working well?
10Why We Do What We Do
- Translate discoveries into products
- Connects to the service mission of the university
- Payback to the taxpayers that support the
university in better products - May generate a cash return
- Generate economic development
- Protect our commercial partners investments with
intellectual property - Enable the commercial partners to invest in the
product - Sometimes is required to commercialize
11Primary Concept
- The main motivation for a university to transfer
technology is an extension of its basic mission
to teach, to generate and share new knowledge,
and to be of service to society. And sometimes
technology transfer generates significant income
for the company partner and the university. By
maintaining the core values of the university
while working with the private and public sectors
to enable development of products, those of us in
the technology transfer profession help change
the world. - Agree? Anything to add?
12Other Impact Points
- What is in the mission statement of every
university - Research
- Education
- Public service/public good
- Can (should) technology commercialization impact
all 3 parts of the mission statement? - Is this how you think about your mission?
13What Is Your Mission?
- How does your technology commercialization
mission support the university mission? - How do you currently measure impact?
- How should you measure impact if you want to
impact the university mission?
14Define Your Mission and Measurements
- How do you want the university to define your
mission? - How do you want to be measured?
15Texas AM System Overview
- OTC Facts
- Evolving Demands
- The Three Paths to Commercialization
- Direct Licensing
- RD Alliances
- Start-Up Formation
- Partnership
16The Office of Technology Commercialization
- Since its founding, the OTC has
- Processed more than 2,400 inventions created by
AM System faculty and staff - Filed more than 2,700 patent applications
- Completed more than 1,700 License Agreements and
Material Transfer Agreements - Generated revenues exceeding 60 million related
to intellectual property rights
17The Office of Technology Commercialization
- Revenues have gone to support
- More than 20 million in sponsored research
- Retention of important faculty
- Support for more than 800 faculty and staff
inventors - Sharing arrangements with co-developers like USDA
and other universities
18The Office of Technology Commercialization
- The OTC
- Became the youngest technology transfer office in
the top 25 in North America in revenues - Is in the top ten in the number of license
agreements producing income - Does two-thirds of its license agreements with
small businesses - Files a patent every other day
- Completes a license agreement once a week
19Impact of License Revenues at Texas AM System
- 10 million in one year.
- Successful?
- Where does that money go?
- 1 million for patent expenses
- 2.25 million to run OTC
- 3.375 million directly to inventors
- 3.375 million spread across System Members with
a combined budget of 3 billion - Is that impactful to Texas AM System?
20In 2005 OTC Defined Commercialization Broadly
- Licensing alone has minimal impact on the mission
of the university - Education
- Research
- Public Service/Public good
- University commercialization must be broader than
licensing - Industry-university partnerships are key to
commercialization success
21Office of Technology Commercialization
- OTC is a matchmaker between System members and
commercial partners - Single point of contact for partners
- OTC works across silos
- OTC defines commercialization broadly
- Licensing
- New venture creation
- Increased research flow
- Assist with new research infrastructure
22Evolving Demands
- OTCs strength has been direct licensing
- This is one of three basic activities that any
technology commercialization office must be
proficient in - As Texas AM becomes more sophisticated, the OTC
is challenged to improve in other areas - The future of the OTC lies in improving our
abilities in the other two sectors of activity
23Scope of OTC Services
- Direct Licensing
- Research and Development Alliances
- Industry
- State/Federal
- Start-Up Formation
24Improving Direct Licensing
- Triage and Assessment
- Preliminary Reports
- Interview Reports
- Communication of Commercialization Plan
- Intellectual Property Strategy
- Marketing Strategy
- Disciplined selection of opportunities
- Follow-through
- Transparency
25Technology Evaluation Matrix
Low Licensing Risk High Licensing Risk
High Reward High Value-Added (Prioritize) Cost Drivers (Make a few smart picks where risk can be reduced close the rest.)
Low Reward Low Value-Added (Maintain low risk, increase reward if possible) Non Value-Added (Waive/Release to Inventors)
26Market Research Reports Help to Manage Risk
Low Licensing Risk High Licensing Risk
High Reward Meet Technical Milestones Cost Drivers
Low Reward Trade Value for Risk Reduction Waive/Release
27Industrial RD Alliances
- Finding corporate partners to bring technology
development forward - In the past, reliance on faculty to initiate
these - Currently, members of licensing staff dedicate
time to pursuit of industry alliances
28(No Transcript)
29 Scope of System Capabilities
- 11 Universities and the Health Science Center
- Campuses in Texas and the Persian Gulf state of
Qatar - 7 state agencies
- 27,000 faculty and staff
- Performed 637 million in externally funded
research - Physical and Program presence in all of the
states 254 counties - In 2008 the AM System
- educated 106,000 students in degree programs
- 22,888 degrees awarded
- More than 1 in 5 students enrolled in a
public university in Texas is attending an AM
System institution - Agencies trained hundreds of thousands more
students through practical extension programs
30Single Point of Contact
- The need is clear, but how?
- The System was the only organization which
spanned the Members - OTCs business focus made it a natural fit for
the job - Referred clients to appropriate
Members/laboratories - Worked across silos
- Recognized synergies between industrial clients
and multiple Members - Initially organized under Business Development in
OTC
31OTC and Business Development(Philosophy of
working with the Marketplace)
- Understanding commercial needs and demands can
uncover collaboration opportunities and potential
funding - Offer need-driven research opportunities to the
researchers - Collaboration opportunities are an outcome of
researchers gaining an understanding of
commercialization - Long-term commercial partnerships lead to
research funding opportunities
32Start Small - Build Upon Success
- Bio-energy efforts were greatly assisted by OTC
- Worked closely with AgriLife Research and
AgriLife researchers - Led to millions of dollars in sponsored research
- Enabled AgriLife to pay for dedicated Corporate
Relations staff - Has led to many more deals in AgriLife with large
industrial partners
33Model is Evolving
- Moving towards a distributed Corporate Relations
model - Multiple offices/people in each of the major
Member organizations - Created a new Associate Vice-Chancellor for
Economic Development - Coordinates efforts and helps to create bridges
between organizations
34Corporate Relations Benchmarks
- University of Wisconsin, Madison
- Office of Corporate Relations, Wisconsin Alumni
Research Foundation, Research Park, WiSys - Purdue University
- Office of Engagement, Office of Technology
Commercialization, Research Park, PURE Database - University of Michigan
- Academic and Corporate Relations Center
35Operational Model
36State and Federal RD Alliances
- Finding state and federal sponsors to bring
technology development forward - These alliances may include industry partners as
well - In the past, reliance on faculty to initiate
these - Currently, senior staff dedicate time to pursuit
of these alliances
37State and Federal RD Alliances
- Guy Diedrich
- Vice Chancellor for Federal Relations and
Commercialization - Mark M. Ellison
- Associate Vice Chancellor for Economic
Development - Dennis Beal
- Director, Industry Alliances
38Get Involved Early
- Build a team of Trusted Technology Advisors for
our two customer bases - University researchers
- industry/investment partners
- Long-term commercial partnerships can lead to
research opportunities - Collaboration opportunities are an outcome of
researchers gaining an understanding of
commercialization
39Start-Up Formation
- Creating companies
- to allow us to move disruptive technologies
forward - to allow us to get a greater return on new
technologies - In the past, reliance on entrepreneurial faculty
to initiate these - Currently, have a dedicated team that focuses on
formation of start-ups
40OTC and Start-up Creation(Establishing New
Business Entities)
- Identify opportunities with start-up potential
for equity investment - Assist with market research, business planning
and partnering (Commercialization Services) - Partnering with early stage capital funds,
investors, and strategic partners - Focus on the relationship and be demand driven
- Provide incubation possibilities at Texas AM or
with partners - Be born big with international presence from the
beginning
41The Pursuit of Regional Knowledge-based
CompetitivenessVISION
- Build global companies from start-up by
leveraging a network of networks built by
technology commercialisation partners around the
world - Technology networks
- VC / High Net Worth Individual networks
- Industry networks
- Management networks
42An Example of The Pursuit of Regional
Knowledge-based Competitiveness
- Memorandum of Understanding (MOU) between
Wallonia Export and Investment on one side and
Texas AM System on the other. - Wallonia is a partner of Texas AM in the
European Union for the commercialisation of their
technologies. - AWEX is the contact point in Belgium for the
realisation of the MOU at all Universities,
Incubators, and Competitiveness Clusters . - The MOU is based on reciprocity.
43Creating a Joint Enterprise
- Co-Identify
- Co-Protect
- Co-Invest
- Co-Locate
- Co-Market
44The Model
Wallonia
Texas
Co-Identify
Co-Protect
Co-Invest
Co-Locate
Co-Market
45The Model
EU
US
China
Middle East
Latin Am
Co-Identify
Co-Protect
Co-Invest
Co-Locate
Co-Market
46Results of Defining Commercialization Broadly
- 170 million in new revenue since 2006
- State industry university research institutes
- State - industry university partnerships to
attract star researchers - Industry university multi-year research
programs - Direct impact on the mission
- Education, research, public good
47Keys to Success
- Top administrator support for commercialization
- Key staff are from industry and speak the
language of business - Commercialization becomes part of the project
design - Industry partners know their ultimate goal is
important to the university as well - Thinking beyond licensing to other possible
business support - Development funding
- New venture creation
48Get Involved Early
- Build a team of Trusted Technology Advisors for
our two customer bases - University researchers
- industry/investment partners
- Long-term commercial partnerships can lead to
research opportunities - Collaboration opportunities are an outcome of
researchers gaining an understanding of
commercialization
49Start-Up Formation
- Creating companies
- to allow us to move disruptive technologies
forward - to allow us to get a greater return on new
technologies - In the past, reliance on entrepreneurial faculty
to initiate these - Currently, have a dedicated team that focuses on
formation of start-ups
50TAMUS Approach
- Inventor led spin-out vs. university led spin-out
- Small equity stake vs large equity stake
- No investment vs cash investment
- No university business involvement vs university
board seats - Part time professor CEO vs full time CEO
- Small university upside vs large university
upside
51What Are Spin-Out Opportunities?
- Goldilocks technologies
- Not developed enough to attract licensees
- Developed enough to attract angels
- Next steps usually involve further research at
the university - Value add step is relatively inexpensive
- Large market fundable, exit strategy
52Example Spin-Out
- MacuClear
- MacuCLEAR completed a Series A private placement
totaling 1.5M to complete preclinical studies
and attain the IND for activation of human
clinical trials. In March 2009, MacuCLEAR also
received follow-on investment of 1.7M from the
Texas Emerging Technology Fund to complete Phase
Ib human trials.
53Example Spin-Out
- Salient
- Salient launched a CASAD Phase Ib human clinical
trial at MD Anderson Cancer Center in Feb 2009,
and trial results are expected in Q1 2010.
Salient has raised 1.5M in convertible debt to
support Phase Ib clinical trials and to fund
ongoing testing at Texas AM University
identifying additional follow-on applications for
CASAD. Salient has also been identified as a
finalist to receive a 2.1M award from the Texas
Emerging Technology Fund to support Phase II/III
trials and follow-on applications.
54Spinouts
- Spinout companies are a tool, not the only tool.
- Example scenarios
- Belsim
- Global BioDiagnostic
- Lisam
55Our goal is not only to discoverknowledge, but
to apply it, Chairman Bill Jones Board of
Regents
56What Tools Can Be Applied In Your Model?
- Portfolio management?
- Involvement in developing industrial
relationships/research programs? - Involvement in strategic research initiatives?
- Economic development mission?
- University led startups?
- International startup partnerships?